BOZZATO, DANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.509
AS - Asia 3.128
EU - Europa 1.798
SA - Sud America 626
AF - Africa 585
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 43
AN - Antartide 1
Totale 12.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.129
SG - Singapore 1.198
CN - Cina 712
BR - Brasile 441
HK - Hong Kong 339
VN - Vietnam 239
PL - Polonia 221
FI - Finlandia 199
IT - Italia 196
SE - Svezia 179
DE - Germania 141
RU - Federazione Russa 90
NL - Olanda 85
GB - Regno Unito 83
FR - Francia 78
UA - Ucraina 58
CA - Canada 51
IN - India 48
MX - Messico 46
ID - Indonesia 39
IQ - Iraq 35
JP - Giappone 34
ES - Italia 33
KR - Corea 32
AR - Argentina 31
BJ - Benin 31
ZA - Sudafrica 31
BW - Botswana 28
SA - Arabia Saudita 28
TR - Turchia 27
AT - Austria 26
EG - Egitto 26
EC - Ecuador 23
IE - Irlanda 23
UG - Uganda 23
CO - Colombia 22
GT - Guatemala 22
PA - Panama 22
PT - Portogallo 22
RO - Romania 22
AZ - Azerbaigian 21
HR - Croazia 21
MD - Moldavia 21
NP - Nepal 21
PR - Porto Rico 21
TJ - Tagikistan 21
AO - Angola 20
LC - Santa Lucia 20
PY - Paraguay 20
TN - Tunisia 20
CL - Cile 19
CW - ???statistics.table.value.countryCode.CW??? 19
DK - Danimarca 19
GF - Guiana Francese 19
LY - Libia 19
BD - Bangladesh 18
BZ - Belize 18
CV - Capo Verde 18
CY - Cipro 18
DO - Repubblica Dominicana 18
EE - Estonia 18
GR - Grecia 18
KZ - Kazakistan 18
TZ - Tanzania 18
AL - Albania 17
BA - Bosnia-Erzegovina 17
BB - Barbados 17
BG - Bulgaria 17
BY - Bielorussia 17
CI - Costa d'Avorio 17
CR - Costa Rica 17
PK - Pakistan 17
SO - Somalia 17
TW - Taiwan 17
AU - Australia 16
EU - Europa 16
GN - Guinea 16
LB - Libano 16
ME - Montenegro 16
PE - Perù 16
SK - Slovacchia (Repubblica Slovacca) 16
UZ - Uzbekistan 16
ZM - Zambia 16
CM - Camerun 15
CU - Cuba 15
CZ - Repubblica Ceca 15
DZ - Algeria 15
GP - Guadalupe 15
IL - Israele 15
JO - Giordania 15
TT - Trinidad e Tobago 15
AD - Andorra 14
BO - Bolivia 14
HU - Ungheria 14
IR - Iran 14
JM - Giamaica 14
KE - Kenya 14
KH - Cambogia 14
MY - Malesia 14
MZ - Mozambico 14
Totale 12.136
Salva come PNG Salva come JPEG
Città #
Singapore 660
Ashburn 624
Woodbridge 621
Chandler 553
Ann Arbor 550
Fairfield 543
Houston 506
Hong Kong 314
Cambridge 217
Wilmington 214
Seattle 193
Bytom 185
Beijing 183
Jacksonville 160
Boardman 155
Santa Clara 133
Des Moines 117
Princeton 114
Medford 103
Helsinki 83
Dong Ket 79
Los Angeles 79
Nanjing 75
Ho Chi Minh City 57
Roxbury 57
San Diego 54
Padova 53
São Paulo 50
New York 39
Hanoi 38
Buffalo 35
Redondo Beach 34
Cotonou 31
Jinan 30
Munich 30
Shenyang 27
Hebei 23
Kampala 23
Warsaw 23
Chicago 22
Nanchang 22
Gaborone 20
Panama City 20
Baku 19
Castries 19
Dushanbe 19
Guangzhou 19
Luanda 19
Tianjin 19
Dallas 18
Cairo 17
Changsha 17
London 17
Tokyo 17
Zhengzhou 17
Dublin 16
Guatemala City 16
Jiaxing 16
Lusaka 16
Praia 16
Abidjan 15
Amsterdam 15
Baghdad 15
Bridgetown 15
Cayenne 15
Chisinau 15
Conakry 15
Dar es Salaam 15
Johannesburg 15
Milan 15
Montreal 15
Toronto 15
Willemstad 15
Andorra la Vella 14
Hefei 14
Kigali 14
Phnom Penh 14
Tallinn 14
Tashkent 14
Turku 14
Vienna 14
Amman 13
Havana 13
Managua 13
Noumea 13
San José 13
Stockholm 13
Tripoli 13
Bamako 12
Dakar 12
Jeddah 12
Lima 12
Nairobi 12
Niamey 12
Nowon-gu 12
Podgorica 12
Rio de Janeiro 12
Riyadh 12
Roseau 12
San Francisco 12
Totale 7.988
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 248
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 235
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 227
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 223
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 214
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 211
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 210
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 188
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 182
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 179
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 176
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 172
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 170
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 169
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 169
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 165
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 165
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 165
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 163
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 155
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 154
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 150
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 150
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 148
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 138
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 135
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 131
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 131
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 130
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 130
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 128
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 128
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 127
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 124
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 122
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 122
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 122
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 122
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 121
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 119
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 119
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 119
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 118
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 118
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 118
NT-S100A8 effects on cell signalling. 116
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 115
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 114
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 113
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 112
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 112
Genome-wide association study identifies an early onset pancreatic cancer risk locus 112
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 111
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 109
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 109
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY 108
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 108
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 106
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 106
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 105
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 105
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 103
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 103
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 102
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 101
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 100
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 99
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 99
The CagL GLU59 Polymorphism of H. pylori is associated with an increasedrisk of gastric cancer. Preliminaryresults from an Italian multicenter study. 98
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 98
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 97
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 97
Polimorfismi dei geni KLK3, RASA1 e NAALADL2: rischio di cancro alla prostata, aggressività della neoplasia e livelli sierici dell’Antigene Prostatico-Specifico 96
Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. 94
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 92
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 91
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 89
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 89
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 89
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival 89
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 88
Erythrocyte sedimentation rate and c-reactive protein in acute inflammation: Meta-analysis of diagnostic accuracy studies 88
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 87
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 87
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 87
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 86
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 84
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 83
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 83
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 82
SMAD4 LOSS ENABLES EGF, TGFB1 AND S100A8/ A9 INDUCED ACTIVATION OF CRITICAL PATHWAYS TO PANCREATIC CANCER INVASION 82
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 81
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 81
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 81
Quality indicators to monitor the rejected outpatients' samples 80
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 79
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 78
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 78
The inflammatory molecules S100A8 and TGF-b1 activate the epithelial-mesenchymal transition (EMT) process in pancreatic cancer (PaCa) cells 78
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 75
Totale 12.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.781
article - articoli 17.260
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021678 0 0 0 0 45 45 34 47 99 133 104 171
2021/2022952 14 182 48 49 43 98 31 75 49 13 65 285
2022/20231.164 206 127 13 131 197 169 4 76 158 9 44 30
2023/2024592 23 70 70 49 46 63 53 65 18 36 40 59
2024/20252.522 14 128 133 121 320 54 118 199 220 96 486 633
2025/20263.854 428 766 1.135 993 532 0 0 0 0 0 0 0
Totale 12.819